ES2051846T3 - 3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos. - Google Patents

3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos.

Info

Publication number
ES2051846T3
ES2051846T3 ES88304975T ES88304975T ES2051846T3 ES 2051846 T3 ES2051846 T3 ES 2051846T3 ES 88304975 T ES88304975 T ES 88304975T ES 88304975 T ES88304975 T ES 88304975T ES 2051846 T3 ES2051846 T3 ES 2051846T3
Authority
ES
Spain
Prior art keywords
alkyl
dihydro
oxo
tiazino
dioxidos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88304975T
Other languages
English (en)
Inventor
Anthony Marfat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2051846T3 publication Critical patent/ES2051846T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

SE PRESENTAN LOS COMPUESTOS DEL TITULO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLE, DONDE R1 ES HIDROGENO, HALOGENO O C1 A C4 ALQUILO; R2 ES HIDROGENO O C1 A C4 ALQUILO Y AR ES FENILO O FENILO SUSTITUIDO CON UNO O MAS SUSTITUYENTES SELECCIONADOS DE C1 A C4 ALQUILO, HALO, TRIFLUOROMETILO, NITRO, HIDROXILO, HALOFENILO O C1 A C4 ALCOXI. LOS COMPUESTOS SON UTILES EN EL TRATAMIENTO DE INFLAMACION U OTRAS ENFERMEDADES MEDIATIZADAS POR LEUCOTRIENO U OTRA PROSTAGLANDINA.
ES88304975T 1987-06-10 1988-06-01 3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos. Expired - Lifetime ES2051846T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001357 WO1988009793A1 (en) 1987-06-10 1987-06-10 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES
EP88304975A EP0294994B1 (en) 1987-06-10 1988-06-01 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides

Publications (1)

Publication Number Publication Date
ES2051846T3 true ES2051846T3 (es) 1994-07-01

Family

ID=55448100

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88304975T Expired - Lifetime ES2051846T3 (es) 1987-06-10 1988-06-01 3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos.

Country Status (28)

Country Link
US (1) US4914101A (es)
EP (1) EP0294994B1 (es)
JP (1) JPH078874B2 (es)
KR (1) KR900006758B1 (es)
CN (1) CN1019576B (es)
AT (1) ATE105561T1 (es)
AU (1) AU593743B2 (es)
CA (1) CA1300625C (es)
CZ (1) CZ281857B6 (es)
DD (1) DD281602A5 (es)
DE (1) DE3889497T2 (es)
DK (1) DK313388A (es)
EG (1) EG18525A (es)
ES (1) ES2051846T3 (es)
FI (1) FI89802C (es)
HU (1) HU203762B (es)
IE (1) IE63214B1 (es)
IL (1) IL86602A (es)
MX (1) MX174093B (es)
MY (1) MY103572A (es)
NO (2) NO176277C (es)
NZ (1) NZ224956A (es)
PH (1) PH25187A (es)
PL (1) PL158994B1 (es)
PT (1) PT87678B (es)
WO (1) WO1988009793A1 (es)
YU (1) YU46767B (es)
ZA (1) ZA884115B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007970A1 (en) * 1989-11-30 1991-06-13 Nippon Hypox Laboratories Incorporated Medicine containing thiazine dioxide derivative
US6340659B1 (en) 1995-12-13 2002-01-22 The Lubrizol Corporation Metal salts of lactones as lubricant additives
JP4250344B2 (ja) 2001-01-29 2009-04-08 インターナショナル・ビジネス・マシーンズ・コーポレーション ワークフローシステム、ワークフローサーバ、および記憶媒体
US8741299B2 (en) 2011-06-20 2014-06-03 The Feinstein Institute For Medical Research Method for treating pathologies associated with hypoxia using MIF inhibitors
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
ZA803401B (en) * 1979-06-13 1981-05-27 Hoffmann La Roche Thiazine derivatives

Also Published As

Publication number Publication date
NO176277C (no) 1995-03-08
NO922636L (no) 1989-02-08
DK313388D0 (da) 1988-06-09
CZ392588A3 (en) 1996-11-13
HU203762B (en) 1991-09-30
MY103572A (en) 1993-08-28
EP0294994B1 (en) 1994-05-11
CZ281857B6 (cs) 1997-03-12
EP0294994A1 (en) 1988-12-14
IL86602A0 (en) 1988-11-30
DK313388A (da) 1988-12-11
CN88103539A (zh) 1988-12-28
JPS6413093A (en) 1989-01-17
PL272928A1 (en) 1989-07-10
PT87678A (pt) 1988-07-01
PT87678B (pt) 1992-10-30
PL158994B1 (pl) 1992-10-30
FI890620A (fi) 1989-02-09
NO176277B (no) 1994-11-28
IL86602A (en) 1992-06-21
ATE105561T1 (de) 1994-05-15
DE3889497T2 (de) 1994-08-25
EG18525A (en) 1994-04-30
NO890531L (no) 1989-02-08
DE3889497D1 (de) 1994-06-16
NO890531D0 (no) 1989-02-08
DD281602A5 (de) 1990-08-15
AU593743B2 (en) 1990-02-15
FI89802C (fi) 1993-11-25
IE881733L (en) 1988-12-10
CA1300625C (en) 1992-05-12
FI89802B (fi) 1993-08-13
YU111988A (en) 1989-12-31
NO922636D0 (no) 1992-07-03
IE63214B1 (en) 1995-04-05
WO1988009793A1 (en) 1988-12-15
AU1753588A (en) 1988-12-15
NZ224956A (en) 1990-07-26
MX174093B (es) 1994-04-21
FI890620A0 (fi) 1989-02-09
JPH078874B2 (ja) 1995-02-01
HUT54376A (en) 1991-02-28
US4914101A (en) 1990-04-03
MX11827A (es) 1993-04-01
PH25187A (en) 1991-03-27
CN1019576B (zh) 1992-12-23
KR900006758B1 (ko) 1990-09-20
ZA884115B (en) 1990-02-28
KR890000500A (ko) 1989-03-15
YU46767B (sh) 1994-05-10

Similar Documents

Publication Publication Date Title
AU7579094A (en) Methods for the treatment of peri-menopausal syndrome
LU88579I2 (fr) ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)
ES8601978A1 (es) Procedimiento para preparar derivados de isoquinoleina
ES2051846T3 (es) 3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos.
DK0769296T3 (da) Anvendelse af et natrium- eller lysiniumsalt af crotonsyreamidderivater til fremstilling af et lægemiddel til behandling af cancer
ATE107280T1 (de) Carbamoyl-2-pyrrolidinonverbindungen.
IT1140847B (it) Tiazoliliden osso propionitrili, mezzi insetticidi contenenti questi composti e processo per la loro preparazione
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
AU538882B2 (en) 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives
HUT63836A (en) Process for producing acridine derivatives
JPS5430163A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts
ES8609254A1 (es) Un procedimiento para preparar un derivado de piridinodicar-boxilato

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 294994

Country of ref document: ES